- ¥1001起订
起订量：
利格列汀杂质 利拉利汀杂质
- 型号
该企业相似产品
深圳远扬化学技术有限公司主营医药标准品，杂质对照品，同位素标准品等，优势供应挪威Chiron标准品，意大利Chromogenix肝素检测试剂，CP，EP，BP，USP，JP，LGC英国政府化学家实验室杂质标准品，TRC加拿大多伦多化学标准品，TLC药物标准品，MOLCAN药物标准品，NIBSC 英国国家生物制品检定所标准试剂， Sigma-Aldrich试剂, 美国ChromaDex中草药标准品，瑞士CaroteNature类胡萝卜素标准品，法国Extrasynthese中草药标准品，WHO世界卫生组织药物标准品，NIST美国国家标准局标准品，IRRM欧洲标准局标准品等各种标准品，CIL美国剑桥同位素标准品，种类齐全，到货迅速。
公司主营以下杂质对照品：卡格列净杂质，依鲁替尼杂质，恩杂鲁胺杂质，奥格列汀杂质，鲁索替尼杂质，西格列汀杂质，奥贝胆酸异构体杂质，托匹司他杂质，利拉列汀杂质，替格瑞洛杂质，普卡必利杂质，艾曲波帕杂质，阿考替胺杂质，索拉非尼杂质，齐拉西酮杂质，盐酸瑞伐拉赞杂质，CO-1686杂质，维格列汀杂质，LCZ696杂质，沙格列汀杂质，佐米曲普坦杂质，尼达尼布杂质，阿法替尼杂质等。
详细信息
利格列汀杂质 利拉利汀杂质?? 产品介绍：
规格：10mg/25mg/50mg/100mg等多种规格可选。
用途：实验研发，药品申报检测，不得用于临床医学诊断。
随货提供：所有杂质对照品均随货提供HPLC，NMR，MS图谱及CoA证书。
国产进口品牌皆有销售，产品库时常更新，部分杂质长期备有库存，可当天发货，另外，我司有专业研发团队，可提供杂质定制服务，以zui大可能的满足您对杂质对照品的选购需求。
利格列汀杂质 利拉利汀杂质?? 杂质列表：
| Linagliptin | (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
| Linagliptin Impurity 1 | 7-(but-2-yn-1-yl)-8-((2-hydroxyethyl)amino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
| Linagliptin Impurity 2 | 2-((R)-3-aminopiperidine-1-carbonyl)-N-((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)benzamide |
| Linagliptin Impurity 3 | (R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
| Linagliptin Impurity 4 | (R,Z)-8-(3-aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
| Linagliptin Impurity 5 | N1,N2-bis((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)phthalamide |
| Linagliptin Impurity 6 | (R)-2-((1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamoyl)benzoic acid |
| Linagliptin Impurity 7 | 8-((R)-3-aminopiperidin-1-yl)-7-((R)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione compound with 8-((R)-3-aminopiperidin-1-yl)-7-((S)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (1:1) |
| Linagliptin Impurity 8 | (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide |
| Linagliptin Impurity 9 | 8-bromo-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione |
| Linagliptin Impurity 10 | (R)-tert-butyl (1-(1,7-di(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
| Linagliptin Impurity 11 | (R)-8-(3-aminopiperidin-1-yl)-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione |
| Linagliptin Impurity 12 | 8-bromo-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
| Linagliptin Impurity 13 | (R)-tert-butyl (1-(3-methyl-7-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
| Linagliptin Impurity 14 | (R)-8-(3-aminopiperidin-1-yl)-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
| Linagliptin Impurity 15 | (R)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-1H-purine-2,6(3H,7H)-dione |
| Linagliptin Impurity 16 | (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide |
| Linagliptin Impurity 17 | (S)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
| Linagliptin Impurity 18 | 7-(but-2-yn-1-yl)-8-(dimethylamino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
| Linagliptin Impurity 19 | N-(2-acetylphenyl)-2-(8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide |
| Linagliptin Impurity 20 | (R)-tert-butyl (1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
| Linagliptin Impurity 21 | (R)-N-(2-acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide |
| Linagliptin Impurity 22 | (R)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
| Linagliptin Impurity 23 | (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione |
| Linagliptin Impurity 24 | (S)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
| Linagliptin Impurity 25 | (R)-7-(but-2-yn-1-yl)-8-(3-((7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)amino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
| Linagliptin Impurity 26 | (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide |
?? 我司主营医药标准品及杂质对照品，以下杂质备有库存，可当天发货，*： 依鲁替尼杂质，奥贝胆酸杂质，依美斯汀杂质，卡格列净杂质，利格列汀杂质，西格列汀杂质，埃索美拉唑杂质，LCZ696杂质，恩杂鲁胺杂质，艾曲波帕杂质，非布司他杂质，托匹司他杂质，乐伐替尼杂质，奥拉帕尼杂质，阿维巴坦杂质，奥美拉唑杂质，普卡必利杂质，西他沙星杂质，泊沙康唑杂质，替格瑞洛杂质，托法替尼杂质，决奈达隆杂质，阿奇霉素杂质等。
?? 美国剑桥CIL标准品部分产品列表：
DLM-277-PK HEXANOIC ACID (D11, 98%)
CLM-9146-0.01 5-ALPHA-DIHYDROTESTOSTERONE 97% CHEMICAL PURITY (2,3,4-13C3,99%)
EDF-4143-1 CALIBRATION CURVE, CDC1 DIOXIN, FURAN, & PCB IN TISSUE IN NONANE
JR-D45-25 1,2,4,6,7,9-HEXACDD UNLABELED ~25 NG/ML IN NONANE
CGM-1000-CN-20-S BIOEXPRESS CELL GROWTH MEDIA (U-13C, 19%; U-15N, 98%) (10X CONCENTRATE)
DLM-2084-PK L-DOPA (RING-D3, 98%)
H-922 ALPHA-HYDROXYMIDAZOLAM UNLABELED 1.0 MG/ML IN METHANOL
CRLM-4396-0 CHROMIUM-54 OXIDE (54Cr)
CLM-1896-PK INDOLE-3-ACETIC ACID (PHENYL-13C6, 99%)
H-049 HYDROMORPHONE (D6, 98%) 100 UG/ML IN METHANOL
EC-5000 WHO COPLANAR & MONO-ORTHO PCB + PCB-170 & PCB-180 UNLABELED 2 UG/ML IN ISOOCTANE
CDLM-7754-PK SUCCINIC ACID (13C4, 99%; 2,2,3,3-D4, 98%)
DLM-143-5X1 1,1,1,3,3,3-HEXAFLUOROISOPROPANOL-D2 (D, 98%)
PCB-170-C 2,2',3,3',4,4',5-HEPTACB UNLABELED
CLM-3876-PK SODIUM OCTANOATE (1,2,3,4-13C4, 99%)
CNLM-6696-PK CELL FREE AMINO ACID MIX (20 AA) (U-13C, 97-99%+; U-15N, 97-99%)
ES-5038-1-10X-1 CLP VOLATILES NON-KETONE DMC 10X STOCK SOLUTION 1000 UG/ML IN METHANOL-OD
EC-1436-1.2 2,2',3,4,4',5'-HEXACB (PCB-138) (13C12, 99%) 40+/-2 UG/ML IN NONANE
CLM-2093-MPT-PK ALPHA-KETOISOCAPROIC ACID, SODIUM SALT (1-13C, 99%) MICROBIOLOGICAL/PYROGEN TESTED
DLM-10-PK DIMETHYL SULFOXIDE-D6 (D, 99.9%)
EDF-5429-CS8H TWO COLUMN DIOXIN & FURAN CALIBRATION SOLUTION CS8H (UNLABELED/13C12, 99%)
CLM-156-MPT-PK SODIUM ACETATE (1-13C, 99%) MICROBIOLOGICAL/PYROGEN TESTED
DLM-6196-1.2 METHYLPHOSPHONIC ACID (METHYL-D3, 98%) 100 UG/ML IN METHANOL
CLM-2456-PK D-XYLOSE (1,2-13C2, 99%)
PCB-166-C 2,3,4,4',5,6-HEXACB UNLABELED
CDLM-7582-SL-1 HIS-UBIQUITIN DC (13C, 98%; D, 98%) *DISCONTINUED*
ULM-9091-1.2 TRIPHENYL PHOSPHATE UNLABELED 1 MG/ML IN ACETONITRILE
DLM-4721-0.5 L-CYSTEINE-N-FMOC, S-TRITYL (3,3-D2, 98%)
更多关于 ?? 的产品信息，请我司获取详情~
